Michael Gwarisa Health authorities are still searching for answers after a cluster of deaths and illnesses in Burundi that has so far defied diagnosis, despite extensive laboratory testing that has ruled out major viral haemorrhagic fevers such as Ebola and Marburg. According to health officials involved in the investigation, hundreds of potential pathogens, including both
Read More
Michael Gwarisa Global efforts to scale up access to a groundbreaking HIV prevention injection have received a major boost after PEPFAR and The Global Fund announced additional investment in Gilead Sciences’ long-acting drug, lenacapavir, with the aim of expanding protection to millions at risk. The new commitment will support access for up to an additional
Read More
Michael Gwarisa For years, the global HIV response has rallied around a simple but powerful message: Undetectable equals Untransmittable, widely known as U=U. Backed by strong scientific evidence, the concept has transformed both HIV prevention and the lives of people living with the virus. But new findings from the Rakai HIV Cohort Study in Uganda
Read More
Michael Gwarisa Amid growing global pressure to make Lenacapavir more affordable, researchers at the Manchester Institute of Biotechnology have developed a new method that could significantly reduce the cost and improve the sustainability of manufacturing the long-acting HIV prevention drug. Supported by funding from the Gates Foundation, the scientists applied engineering biology, a rapidly advancing
Read More
Michael Gwarisa The Medicines Control Authority of Zimbabwe (MCAZ) has issued a Class II recall of a specific batch of Azithromycin 500mg USP tablets after a quality defect was detected, raising concerns over the drug’s effectiveness in treating bacterial infections. The affected product, Batch Number 24050191, was manufactured by Indoco Remedies Limited of India. According
Read More
Michael Gwarisa Zimbabwe’s leading family planning expert and trainer with the Zimbabwe National Family Planning Council (ZNFPC), Thandekile Munemo, has cautioned women against closely spaced pregnancies, warning that insufficient recovery time between births can pose serious health risks for both mothers and children. The concept of “gore mwana mwawa”, a Shona phrase loosely translated as
Read More
Michael Gwarisa The World Health Organization (WHO) is supporting Burundi’s efforts to determine the cause of an illness that has led to five deaths and infected 35 people in Mpanda district, north of the East African country. While preliminary assumptions linked the ailment to Ebola or Marburg virus diseases, Rift Valley fever, yellow fever and
Read More
Michael Gwarisa Amid declining donor support for health programmes in Africa and globally, the European Union has committed US$750 million (€700 million) to the Global Fund’s 8th replenishment to strengthen the fight against HIV, tuberculosis and malaria. The announcement was made by Jozef Síkela, Commissioner for International Partnerships, at the One Health Summit in Lyon,
Read More
Michael Gwarisa A team from Imperial College London has travelled to Zimbabwe to deliver an intensive training programme aimed at strengthening the use of machine learning in healthcare, as global efforts grow to harness artificial intelligence for improved health outcomes. The three day course, titled Machine Learning for Health Applications, was held in Harare from
Read More
Michael Gwarisa Maternal anaemia is tightening its grip on Zimbabwe, with the latest Zimbabwe Demographic and Health Survey (ZDHS) revealing a sharp and worrying rise over the past decade. In 2015, 27 percent of women of childbearing age (15 to 49) were anaemic. Today, that figure has climbed to 41.8 percent, a nearly 55 percent
Read More